Compile Data Set for Download or QSAR

Found 379 hits Enz. Inhib. hit(s) with all data for assayid = 2 entry = 6684   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146458 (US8957068, 590) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCC3)c(F)c2)n1 |r| Show InChI InChI=1S/C24H30FN5O3/c1-14(2)20-13-33-24(32)30(20)21-10-11-26-23(29-21)27-15(3)16-8-9-18(19(25)12-16)22(31)28-17-6-4-5-7-17/h8-12,14-15,17,20H,4-7,13H2,1-3H3,(H,28,31)(H,26,27,29)/t15-,20+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7.5	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146444 (US8957068, 573) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCCC3)c(F)c2)n1 |r| Show InChI InChI=1S/C25H32FN5O3/c1-15(2)21-14-34-25(33)31(21)22-11-12-27-24(30-22)28-16(3)17-9-10-19(20(26)13-17)23(32)29-18-7-5-4-6-8-18/h9-13,15-16,18,21H,4-8,14H2,1-3H3,(H,29,32)(H,27,28,30)/t16-,21+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7.86	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146403 (US8957068, 531) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCCC3)c(Cl)c2)n1 |r| Show InChI InChI=1S/C25H32ClN5O3/c1-15(2)21-14-34-25(33)31(21)22-11-12-27-24(30-22)28-16(3)17-9-10-19(20(26)13-17)23(32)29-18-7-5-4-6-8-18/h9-13,15-16,18,21H,4-8,14H2,1-3H3,(H,29,32)(H,27,28,30)/t16-,21+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8.12	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146402 (US8957068, 530) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCC3)c(Cl)c2)n1 |r| Show InChI InChI=1S/C24H30ClN5O3/c1-14(2)20-13-33-24(32)30(20)21-10-11-26-23(29-21)27-15(3)16-8-9-18(19(25)12-16)22(31)28-17-6-4-5-7-17/h8-12,14-15,17,20H,4-7,13H2,1-3H3,(H,28,31)(H,26,27,29)/t15-,20+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8.35	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146334 (US8957068, 457) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(cn2)-c2cccc(c2)C(F)(F)F)n1 |r| Show InChI InChI=1S/C23H23F3N6O2/c1-13(2)18-12-34-22(33)32(18)19-7-8-27-21(31-19)30-14(3)20-28-10-16(11-29-20)15-5-4-6-17(9-15)23(24,25)26/h4-11,13-14,18H,12H2,1-3H3,(H,27,30,31)/t14-,18+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146183 (US8957068, 235) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(CC3)C(=O)OCc3ccccc3)cc2)n1 |r| Show InChI InChI=1S/C31H38N6O4/c1-22(2)27-21-41-31(39)37(27)28-13-14-32-29(34-28)33-23(3)26-11-9-24(10-12-26)19-35-15-17-36(18-16-35)30(38)40-20-25-7-5-4-6-8-25/h4-14,22-23,27H,15-21H2,1-3H3,(H,32,33,34)/t23-,27+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	14.1	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146172 (US8957068, 224) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(F)(F)CC3)cc2)n1 |r| Show InChI InChI=1S/C24H31F2N5O2/c1-16(2)20-15-33-23(32)31(20)21-8-11-27-22(29-21)28-17(3)19-6-4-18(5-7-19)14-30-12-9-24(25,26)10-13-30/h4-8,11,16-17,20H,9-10,12-15H2,1-3H3,(H,27,28,29)/t17-,20+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem Similars	US Patent	n/a	n/a	16.6	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146155 (US8957068, 207) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(cc2)-c2ccnc(C)c2)n1 |r| Show InChI InChI=1S/C24H27N5O2/c1-15(2)21-14-31-24(30)29(21)22-10-12-26-23(28-22)27-17(4)18-5-7-19(8-6-18)20-9-11-25-16(3)13-20/h5-13,15,17,21H,14H2,1-4H3,(H,26,27,28)/t17-,21+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	16.9	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146173 (US8957068, 225) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCC(CC3)OCC(F)(F)F)c(F)c2)n1 |r,wU:15.16,wD:3.2,(9.9,-1.54,;9.13,-.21,;7.59,-.21,;9.9,1.13,;11.44,1.13,;11.92,2.59,;10.67,3.5,;10.67,5.04,;9.42,2.59,;8.09,3.36,;8.09,4.9,;6.76,5.67,;5.42,4.9,;5.42,3.36,;4.09,2.59,;4.09,1.05,;5.42,.28,;2.76,.28,;2.76,-1.26,;1.42,-2.03,;.09,-1.26,;-1.25,-2.03,;-1.25,-3.57,;-2.58,-1.26,;-3.91,-2.03,;-5.25,-1.26,;-6.58,-2.03,;-6.58,-3.57,;-5.25,-4.34,;-3.91,-3.57,;-7.91,-4.34,;-9.25,-3.57,;-9.25,-2.03,;-9.25,-.49,;-7.71,-2.03,;-10.79,-2.03,;.09,.28,;-1.25,1.05,;1.42,1.05,;6.76,2.59,)| Show InChI InChI=1S/C27H33F4N5O4/c1-15(2)22-13-39-26(38)36(22)23-10-11-32-25(35-23)33-16(3)17-4-9-20(21(28)12-17)24(37)34-18-5-7-19(8-6-18)40-14-27(29,30)31/h4,9-12,15-16,18-19,22H,5-8,13-14H2,1-3H3,(H,34,37)(H,32,33,35)/t16-,18?,19?,22+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	17.3	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146459 (US8957068, 591) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCC(F)(F)CC3)c(F)c2)n1 |r| Show InChI InChI=1S/C25H30F3N5O3/c1-14(2)20-13-36-24(35)33(20)21-8-11-29-23(32-21)30-15(3)16-4-5-18(19(26)12-16)22(34)31-17-6-9-25(27,28)10-7-17/h4-5,8,11-12,14-15,17,20H,6-7,9-10,13H2,1-3H3,(H,31,34)(H,29,30,32)/t15-,20+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146423 (US8957068, 552) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCCC(F)(F)C3)cc2)n1 |r| Show InChI InChI=1S/C24H31F2N5O2/c1-16(2)20-14-33-23(32)31(20)21-9-11-27-22(29-21)28-17(3)19-7-5-18(6-8-19)13-30-12-4-10-24(25,26)15-30/h5-9,11,16-17,20H,4,10,12-15H2,1-3H3,(H,27,28,29)/t17-,20+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	19.9	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146164 (US8957068, 216) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)(C)C3)c(F)c2)n1 |r| Show InChI InChI=1S/C26H37FN6O2/c1-17(2)22-15-35-25(34)33(22)23-9-10-28-24(30-23)29-18(3)19-7-8-20(21(27)13-19)14-32-12-11-31(6)26(4,5)16-32/h7-10,13,17-18,22H,11-12,14-16H2,1-6H3,(H,28,29,30)/t18-,22+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	20.6	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146396 (US8957068, 524) Show SMILES CCOC1(CC1)c1ccc(cc1)[C@H](C)Nc1nccc(n1)N1[C@H](COC1=O)C(C)C |r| Show InChI InChI=1S/C23H30N4O3/c1-5-30-23(11-12-23)18-8-6-17(7-9-18)16(4)25-21-24-13-10-20(26-21)27-19(15(2)3)14-29-22(27)28/h6-10,13,15-16,19H,5,11-12,14H2,1-4H3,(H,24,25,26)/t16-,19+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	21.1	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146213 (US8957068, 265) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccc(F)cc3)cc2)n1 |r| Show InChI InChI=1S/C24H25FN4O3/c1-15(2)21-14-31-24(30)29(21)22-12-13-26-23(28-22)27-16(3)17-4-8-19(9-5-17)32-20-10-6-18(25)7-11-20/h4-13,15-16,21H,14H2,1-3H3,(H,26,27,28)/t16-,21+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	23.2	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146260 (US8957068, 312) Show SMILES CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2)ncc1F |r| Show InChI InChI=1S/C25H34FN5O3/c1-15(2)22-14-33-25(32)31(22)23-21(26)10-27-24(29-23)28-18(5)20-8-6-19(7-9-20)13-30-11-16(3)34-17(4)12-30/h6-10,15-18,22H,11-14H2,1-5H3,(H,27,28,29)/t16-,17+,18-,22+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146160 (US8957068, 212) Show SMILES C[C@H](Nc1ncc(F)c(n1)N1C(=O)OCC11CCCC1)c1ccc(Oc2ccccc2)cc1 |r| Show InChI InChI=1S/C25H25FN4O3/c1-17(18-9-11-20(12-10-18)33-19-7-3-2-4-8-19)28-23-27-15-21(26)22(29-23)30-24(31)32-16-25(30)13-5-6-14-25/h2-4,7-12,15,17H,5-6,13-14,16H2,1H3,(H,27,28,29)/t17-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146327 (US8957068, 444 | US8957068, 445) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2ccc(cn2)-c2ccc(F)c(C)c2)n1 |r,w:15.16| Show InChI InChI=1S/C24H26FN5O2/c1-14(2)21-13-32-24(31)30(21)22-9-10-26-23(29-22)28-16(4)20-8-6-18(12-27-20)17-5-7-19(25)15(3)11-17/h5-12,14,16,21H,13H2,1-4H3,(H,26,28,29)/t16?,21-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	26.6	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146274 (US8957068, 339 | US8957068, 340) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2ccc(cc2)N(C)c2ccccc2)n1 |r,w:15.16| Show InChI InChI=1S/C25H29N5O2/c1-17(2)22-16-32-25(31)30(22)23-14-15-26-24(28-23)27-18(3)19-10-12-21(13-11-19)29(4)20-8-6-5-7-9-20/h5-15,17-18,22H,16H2,1-4H3,(H,26,27,28)/t18?,22-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	27.6	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146275 (US8957068, 341 | US8957068, 342) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2ccc(c(F)c2)-n2cc(C)cn2)n1 |r,w:15.16| Show InChI InChI=1S/C22H25FN6O2/c1-13(2)19-12-31-22(30)29(19)20-7-8-24-21(27-20)26-15(4)16-5-6-18(17(23)9-16)28-11-14(3)10-25-28/h5-11,13,15,19H,12H2,1-4H3,(H,24,26,27)/t15?,19-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	27.8	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146387 (US8957068, 515) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(cc2F)C2(C)CC2)n1 |r| Show InChI InChI=1S/C22H27FN4O2/c1-13(2)18-12-29-21(28)27(18)19-7-10-24-20(26-19)25-14(3)16-6-5-15(11-17(16)23)22(4)8-9-22/h5-7,10-11,13-14,18H,8-9,12H2,1-4H3,(H,24,25,26)/t14-,18+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	28.7	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146382 (US8957068, 510 | US8957068, 514) Show SMILES C[C@H](Nc1nc(Cl)cc(n1)N1C(=O)OCC1(C)C)c1nc(no1)-c1ccc(Cl)cc1 |r| Show InChI InChI=1S/C19H18Cl2N6O3/c1-10(16-25-15(26-30-16)11-4-6-12(20)7-5-11)22-17-23-13(21)8-14(24-17)27-18(28)29-9-19(27,2)3/h4-8,10H,9H2,1-3H3,(H,22,23,24)/t10-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	29.4	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146127 (US8957068, 162) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccccc3)cc2)n1 |r| Show InChI InChI=1S/C24H26N4O3/c1-16(2)21-15-30-24(29)28(21)22-13-14-25-23(27-22)26-17(3)18-9-11-20(12-10-18)31-19-7-5-4-6-8-19/h4-14,16-17,21H,15H2,1-3H3,(H,25,26,27)/t17-,21+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	31.5	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146385 (US8957068, 513) Show SMILES C[C@H](Nc1nc(F)cc(n1)N1C(=O)OCC1(C)C)c1nc(no1)-c1ccc(Cl)cc1 |r| Show InChI InChI=1S/C19H18ClFN6O3/c1-10(16-25-15(26-30-16)11-4-6-12(20)7-5-11)22-17-23-13(21)8-14(24-17)27-18(28)29-9-19(27,2)3/h4-8,10H,9H2,1-3H3,(H,22,23,24)/t10-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	33.6	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146129 (US8957068, 164) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(cc2)C(C)(C)C)n1 |r| Show InChI InChI=1S/C22H30N4O2/c1-14(2)18-13-28-21(27)26(18)19-11-12-23-20(25-19)24-15(3)16-7-9-17(10-8-16)22(4,5)6/h7-12,14-15,18H,13H2,1-6H3,(H,23,24,25)/t15-,18+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	33.9	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146175 (US8957068, 227) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN4CCCC4C3)c(F)c2)n1 |r| Show InChI InChI=1S/C26H35FN6O2/c1-17(2)23-16-35-26(34)33(23)24-8-9-28-25(30-24)29-18(3)19-6-7-20(22(27)13-19)14-31-11-12-32-10-4-5-21(32)15-31/h6-9,13,17-18,21,23H,4-5,10-12,14-16H2,1-3H3,(H,28,29,30)/t18-,21?,23+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	33.9	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146470 (US8957068, 602) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCC(F)CC3)c(F)c2)n1 |r| Show InChI InChI=1S/C24H29F2N5O3/c1-14(2)20-13-34-24(33)31(20)21-6-9-27-23(29-21)28-15(3)16-4-5-18(19(26)12-16)22(32)30-10-7-17(25)8-11-30/h4-6,9,12,14-15,17,20H,7-8,10-11,13H2,1-3H3,(H,27,28,29)/t15-,20+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146461 (US8957068, 593) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@@H]3CCCC[C@@H]3O)c(F)c2)n1 |r| Show InChI InChI=1S/C25H32FN5O4/c1-14(2)20-13-35-25(34)31(20)22-10-11-27-24(30-22)28-15(3)16-8-9-17(18(26)12-16)23(33)29-19-6-4-5-7-21(19)32/h8-12,14-15,19-21,32H,4-7,13H2,1-3H3,(H,29,33)(H,27,28,30)/t15-,19+,20+,21-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	36	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146329 (US8957068, 448 | US8957068, 449) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2ccc(Oc3ccc(F)cc3)cn2)n1 |r,w:15.16| Show InChI InChI=1S/C23H24FN5O3/c1-14(2)20-13-31-23(30)29(20)21-10-11-25-22(28-21)27-15(3)19-9-8-18(12-26-19)32-17-6-4-16(24)5-7-17/h4-12,14-15,20H,13H2,1-3H3,(H,25,27,28)/t15?,20-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	37.3	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146340 (US8957068, 464) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2ncc(cn2)-c2ccc(F)c(C)c2)n1 |r,w:15.16| Show InChI InChI=1S/C23H25FN6O2/c1-13(2)19-12-32-23(31)30(19)20-7-8-25-22(29-20)28-15(4)21-26-10-17(11-27-21)16-5-6-18(24)14(3)9-16/h5-11,13,15,19H,12H2,1-4H3,(H,25,28,29)/t15?,19-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	37.5	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146316 (US8957068, 425 | US8957068, 426) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2nc(no2)-c2ccc(Cl)cc2)n1 |r,w:15.16| Show InChI InChI=1S/C20H21ClN6O3/c1-11(2)15-10-29-20(28)27(15)16-8-9-22-19(24-16)23-12(3)18-25-17(26-30-18)13-4-6-14(21)7-5-13/h4-9,11-12,15H,10H2,1-3H3,(H,22,23,24)/t12?,15-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	38.5	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146328 (US8957068, 446 | US8957068, 447) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2ncc(Oc3ccc(F)cc3)cn2)n1 |r,w:15.16| Show InChI InChI=1S/C22H23FN6O3/c1-13(2)18-12-31-22(30)29(18)19-8-9-24-21(28-19)27-14(3)20-25-10-17(11-26-20)32-16-6-4-15(23)5-7-16/h4-11,13-14,18H,12H2,1-3H3,(H,24,27,28)/t14?,18-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	39	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146434 (US8957068, 563) Show SMILES CC(C)COc1ccc(cc1)[C@H](C)Nc1nccc(n1)N1[C@H](COC1=O)C(C)C |r| Show InChI InChI=1S/C22H30N4O3/c1-14(2)12-28-18-8-6-17(7-9-18)16(5)24-21-23-11-10-20(25-21)26-19(15(3)4)13-29-22(26)27/h6-11,14-16,19H,12-13H2,1-5H3,(H,23,24,25)/t16-,19+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	40	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146333 (US8957068, 456) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2ncc(Oc3ccc(F)cc3F)cn2)n1 |r,w:15.16| Show InChI InChI=1S/C22H22F2N6O3/c1-12(2)17-11-32-22(31)30(17)19-6-7-25-21(29-19)28-13(3)20-26-9-15(10-27-20)33-18-5-4-14(23)8-16(18)24/h4-10,12-13,17H,11H2,1-3H3,(H,25,28,29)/t13?,17-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	41	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146253 (US8957068, 305) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(Oc3ccc(F)c(Cl)c3)cn2)n1 |r| Show InChI InChI=1S/C22H22ClFN6O3/c1-12(2)18-11-32-22(31)30(18)19-6-7-25-21(29-19)28-13(3)20-26-9-15(10-27-20)33-14-4-5-17(24)16(23)8-14/h4-10,12-13,18H,11H2,1-3H3,(H,25,28,29)/t13-,18+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	41.3	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146326 (US8957068, 443) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2noc(n2)-c2ccc(Cl)cc2)n1 |r,w:15.16| Show InChI InChI=1S/C20H21ClN6O3/c1-11(2)15-10-29-20(28)27(15)16-8-9-22-19(24-16)23-12(3)17-25-18(30-26-17)13-4-6-14(21)7-5-13/h4-9,11-12,15H,10H2,1-3H3,(H,22,23,24)/t12?,15-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	41.4	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146178 (US8957068, 230) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN4CCCCC4C3)cc2)n1 |r| Show InChI InChI=1S/C27H38N6O2/c1-19(2)24-18-35-27(34)33(24)25-11-12-28-26(30-25)29-20(3)22-9-7-21(8-10-22)16-31-14-15-32-13-5-4-6-23(32)17-31/h7-12,19-20,23-24H,4-6,13-18H2,1-3H3,(H,28,29,30)/t20-,23?,24+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	41.5	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146469 (US8957068, 601) Show SMILES COC1CCN(CC1)C(=O)c1ccc(cc1F)[C@H](C)Nc1nccc(n1)N1[C@H](COC1=O)C(C)C |r| Show InChI InChI=1S/C25H32FN5O4/c1-15(2)21-14-35-25(33)31(21)22-7-10-27-24(29-22)28-16(3)17-5-6-19(20(26)13-17)23(32)30-11-8-18(34-4)9-12-30/h5-7,10,13,15-16,18,21H,8-9,11-12,14H2,1-4H3,(H,27,28,29)/t16-,21+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	42	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146418 (US8957068, 546) Show SMILES CC(C)COc1ccc(cc1C)[C@H](C)Nc1nccc(n1)N1[C@H](COC1=O)C(C)C |r| Show InChI InChI=1S/C23H32N4O3/c1-14(2)12-29-20-8-7-18(11-16(20)5)17(6)25-22-24-10-9-21(26-22)27-19(15(3)4)13-30-23(27)28/h7-11,14-15,17,19H,12-13H2,1-6H3,(H,24,25,26)/t17-,19+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	42.3	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146398 (US8957068, 526) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(cc2F)C(C)C)n1 |r| Show InChI InChI=1S/C21H27FN4O2/c1-12(2)15-6-7-16(17(22)10-15)14(5)24-20-23-9-8-19(25-20)26-18(13(3)4)11-28-21(26)27/h6-10,12-14,18H,11H2,1-5H3,(H,23,24,25)/t14-,18+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	42.7	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146441 (US8957068, 570) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCCCC3)c(F)c2)n1 |r| Show InChI InChI=1S/C24H30FN5O3/c1-15(2)20-14-33-24(32)30(20)21-9-10-26-23(28-21)27-16(3)17-7-8-18(19(25)13-17)22(31)29-11-5-4-6-12-29/h7-10,13,15-16,20H,4-6,11-12,14H2,1-3H3,(H,26,27,28)/t16-,20+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	44.6	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146320 (US8957068, 431 | US8957068, 432) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2cnc(s2)-c2ccccc2)n1 |r,w:15.16| Show InChI InChI=1S/C21H23N5O2S/c1-13(2)16-12-28-21(27)26(16)18-9-10-22-20(25-18)24-14(3)17-11-23-19(29-17)15-7-5-4-6-8-15/h4-11,13-14,16H,12H2,1-3H3,(H,22,24,25)/t14?,16-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	44.8	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146176 (US8957068, 228) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(CC3)C3CC3)cc2)n1 |r| Show InChI InChI=1S/C26H36N6O2/c1-18(2)23-17-34-26(33)32(23)24-10-11-27-25(29-24)28-19(3)21-6-4-20(5-7-21)16-30-12-14-31(15-13-30)22-8-9-22/h4-7,10-11,18-19,22-23H,8-9,12-17H2,1-3H3,(H,27,28,29)/t19-,23+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	46.3	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146198 (US8957068, 250) Show SMILES C[C@H](Nc1nccc(n1)N1C(=O)OC[C@]1(C)c1ccccc1)c1ccc(Oc2ccccc2)cc1 |r| Show InChI InChI=1S/C28H26N4O3/c1-20(21-13-15-24(16-14-21)35-23-11-7-4-8-12-23)30-26-29-18-17-25(31-26)32-27(33)34-19-28(32,2)22-9-5-3-6-10-22/h3-18,20H,19H2,1-2H3,(H,29,30,31)/t20-,28+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	46.8	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146169 (US8957068, 221) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)(C)C3)cc2)n1 |r| Show InChI InChI=1S/C26H38N6O2/c1-18(2)22-16-34-25(33)32(22)23-11-12-27-24(29-23)28-19(3)21-9-7-20(8-10-21)15-31-14-13-30(6)26(4,5)17-31/h7-12,18-19,22H,13-17H2,1-6H3,(H,27,28,29)/t19-,22+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	47.6	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146416 (US8957068, 544) Show SMILES CC(C)COc1ccc([C@H](C)Nc2nccc(n2)N2[C@H](COC2=O)C(C)C)c(C)c1 |r| Show InChI InChI=1S/C23H32N4O3/c1-14(2)12-29-18-7-8-19(16(5)11-18)17(6)25-22-24-10-9-21(26-22)27-20(15(3)4)13-30-23(27)28/h7-11,14-15,17,20H,12-13H2,1-6H3,(H,24,25,26)/t17-,20+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	47.7	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146435 (US8957068, 564) Show SMILES CC(C)COc1ccc(cc1)[C@H](C)Nc1ncc(F)c(n1)N1[C@H](COC1=O)C(C)C |r| Show InChI InChI=1S/C22H29FN4O3/c1-13(2)11-29-17-8-6-16(7-9-17)15(5)25-21-24-10-18(23)20(26-21)27-19(14(3)4)12-30-22(27)28/h6-10,13-15,19H,11-12H2,1-5H3,(H,24,25,26)/t15-,19+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	50.1	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146188 (US8957068, 240) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(cc2)C(=O)NC2CCCCC2)n1 |r| Show InChI InChI=1S/C25H33N5O3/c1-16(2)21-15-33-25(32)30(21)22-13-14-26-24(29-22)27-17(3)18-9-11-19(12-10-18)23(31)28-20-7-5-4-6-8-20/h9-14,16-17,20-21H,4-8,15H2,1-3H3,(H,28,31)(H,26,27,29)/t17-,21+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	50.6	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146330 (US8957068, 450 | US8957068, 451) Show SMILES CC(Nc1ncc(F)c(n1)N1[C@H](c2ccccc2)C(C)(C)OC1=O)c1ccc(Oc2ccc(F)cc2)cn1 |r,w:1.0| Show InChI InChI=1S/C28H25F2N5O3/c1-17(23-14-13-21(15-31-23)37-20-11-9-19(29)10-12-20)33-26-32-16-22(30)25(34-26)35-24(18-7-5-4-6-8-18)28(2,3)38-27(35)36/h4-17,24H,1-3H3,(H,32,33,34)/t17?,24-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	51.8	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146222 (US8957068, 274) Show SMILES C[C@H](Nc1nccc(n1)N1[C@@H](c2ccccc2)C(C)(C)OC1=O)c1ccc(CN2CCN(C)CC2)cc1 |r| Show InChI InChI=1S/C29H36N6O2/c1-21(23-12-10-22(11-13-23)20-34-18-16-33(4)17-19-34)31-27-30-15-14-25(32-27)35-26(24-8-6-5-7-9-24)29(2,3)37-28(35)36/h5-15,21,26H,16-20H2,1-4H3,(H,30,31,32)/t21-,26-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	52.4	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic (Homo sapiens (Human))	BDBM146463 (US8957068, 595) Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@@H]3CCCC[C@H]3O)c(F)c2)n1 |r| Show InChI InChI=1S/C25H32FN5O4/c1-14(2)20-13-35-25(34)31(20)22-10-11-27-24(30-22)28-15(3)16-8-9-17(18(26)12-16)23(33)29-19-6-4-5-7-21(19)32/h8-12,14-15,19-21,32H,4-7,13H2,1-3H3,(H,29,33)(H,27,28,30)/t15-,19+,20+,21+/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	53	n/a	n/a	n/a	n/a	7.5	25
Novartis AG US Patent					Assay Description The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...				US Patent US8957068 (2015) BindingDB Entry DOI: 10.7270/Q2TD9W28
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 379 total )  |  Next  |  Last  >>

Jump to: